| The direct and indirect costs associated with endometriosis: a systematic literature review AM Soliman, H Yang, EX Du, C Kelley, C Winkel Human reproduction 31 (4), 712-722, 2016 | 225 | 2016 |
| The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013 AM Soliman, H Yang, EX Du, SS Kelkar, C Winkel American journal of obstetrics and gynecology 213 (2), 141-160, 2015 | 117 | 2015 |
| Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases M Fuldeore, H Yang, EX Du, AM Soliman, EQ Wu, C Winkel Fertility and sterility 103 (1), 163-171, 2015 | 100 | 2015 |
| Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review EQ Wu, P Hodgkins, R Ben-Hamadi, J Setyawan, J Xie, V Sikirica, EX Du, ... CNS drugs 26, 581-600, 2012 | 73 | 2012 |
| Comparative efficacy of JAK inhibitors for moderate-to-severe rheumatoid arthritis: a network meta-analysis J Pope, R Sawant, N Tundia, EX Du, CZ Qi, Y Song, P Tang, KA Betts Advances in therapy 37, 2356-2372, 2020 | 50 | 2020 |
| Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis JF Donohue, KA Betts, EX Du, P Altman, P Goyal, DL Keininger, ... International journal of chronic obstructive pulmonary disease, 367-381, 2017 | 45 | 2017 |
| Real-world outcomes of acute ischemic stroke treatment with intravenous recombinant tissue plasminogen activator KA Betts, D Hurley, J Song, G Sajeev, J Guo, EX Du, M Paschoalin, ... Journal of Stroke and Cerebrovascular Diseases 26 (9), 1996-2003, 2017 | 34 | 2017 |
| Treatment patterns, complications, and health care utilization among endometriosis patients undergoing a laparoscopy or a hysterectomy: a retrospective claims analysis ES Surrey, AM Soliman, H Yang, EX Du, B Su Advances in Therapy 34, 2436-2451, 2017 | 33 | 2017 |
| Retreatment rates among endometriosis patients undergoing hysterectomy or laparoscopy AM Soliman, EX Du, H Yang, EQ Wu, JC Haley Journal of Women's Health 26 (6), 644-654, 2017 | 33 | 2017 |
| Real-world palbociclib dosing patterns and implications for drug costs in the treatment of HR+/HER2-metastatic breast cancer N Li, EX Du, L Chu, M Peeples, J Xie, V Barghout, DH Tang Expert opinion on pharmacotherapy 18 (12), 1167-1178, 2017 | 24 | 2017 |
| Economic burden of switching to a non-tumor necrosis factor inhibitor versus a tumor necrosis factor inhibitor biologic therapy among patients with rheumatoid arthritis ZY Zhou, J Griffith, EX Du, D Chin, KA Betts, A Ganguli Advances in therapy 33, 807-823, 2016 | 22 | 2016 |
| Systematic literature review and meta-analysis of tumor necrosis factor–alpha experienced rheumatoid arthritis AF Wells, JR Curtis, KA Betts, K Douglas, EX Du, A Ganguli Clinical Therapeutics 39 (8), 1680-1694. e2, 2017 | 21 | 2017 |
| Estimating the value of the reduction in air pollution during the Beijing Olympics X Du, RO Mendelsohn Environment and Development Economics 16 (6), 735-749, 2011 | 21 | 2011 |
| Matching-adjusted indirect comparisons of efficacy of BAY 81-8973 vs two recombinant factor VIII for the prophylactic treatment of severe hemophilia A J Pocoski, N Li, R Ayyagari, N Church, M Maas Enriquez, Q Xiang, ... Journal of Blood Medicine, 129-137, 2016 | 13 | 2016 |
| A Matching-adjusted indirect comparison of upadacitinib versus tofacitinib in adults with moderate-to-severe rheumatoid arthritis CJ Edwards, R Sawant, V Garg, EX Du, A Friedman, KA Betts Rheumatology and Therapy 8, 167-181, 2021 | 11 | 2021 |
| US cost–effectiveness of polatuzumab vedotin, bendamustine and rituximab in diffuse large B-cell lymphoma KA Betts, PO Thuresson, F Felizzi, EX Du, I Dieye, J Li, M Schulz, ... Journal of comparative effectiveness research 9 (14), 1003-1015, 2020 | 11 | 2020 |
| Indirect treatment comparison of nivolumab versus observation or ipilimumab as adjuvant therapy in resected melanoma using pooled clinical trial data M Freeman, KA Betts, S Jiang, EX Du, K Gupte-Singh, Y Lu, S Rao, ... Advances in therapy 36, 2783-2796, 2019 | 10 | 2019 |
| Treatment, monitoring, and economic outcomes of venous thromboembolism among hospitalized patients in China EQ Wu, J Xie, C Wu, EX Du, N Li, R Tan, Y Liu PharmacoEconomics 32, 305-313, 2014 | 8 | 2014 |
| Characteristics and treatment patterns of relapsed/refractory diffuse large B-cell lymphoma in patients receiving≥ 3 therapy lines in post-CAR-T era J Xie, A Wu, L Liao, LJ Nastoupil, EX Du, A Noman, L Chen Current Medical Research and Opinion 37 (10), 1789-1798, 2021 | 6 | 2021 |
| Indirect treatment comparison of nivolumab versus placebo as an adjuvant therapy for resected melanoma. AN Shoushtari, ML Freeman, KA Betts, K Gupte-Singh, EX Du, ... Journal of Clinical Oncology 36 (15_suppl), 9593-9593, 2018 | 6 | 2018 |
Keith BettsAnalysis Group, Inc.Verified email at analysisgroup.com
